Showing results (101-110 of 492) with videos related to
Sort By:
Pageof 50
JAMA Network Open|March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial ParticipationAngela K Green, Sara M Tabatabai, Xing Bai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune diseaseOla Landgren, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.Seminars in Hematology|January 15, 2011
Molecular imaging in myeloma precursor diseaseEsther Mena, Peter Choyke, Esther Tan, et al.Seminars in Hematology|January 15, 2011
Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunitiesAlex R Minter, Haley Simpson, Brendan M Weiss, et al.British Journal of Haematology|June 6, 2020
The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?Dickran Kazandjian, Clifton C Mo, Ola Landgren, et al.Current Oncology Reports|April 27, 2024
Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and OpinionsMina Meseha, James Hoffman, Dickran Kazandjian, et al.BMJ (Clinical Research Ed.)|March 9, 2018
Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational studyJeffrey Wagner, John Marquart, Julia Ruby, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple MyelomaMalin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.Research Square|March 3, 2023
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple MyelomaCarlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.Cancer Journal (Sudbury, Mass.)|April 25, 2009
Current insight on trends, causes, and mechanisms of Hodgkin's lymphomaNeil E Caporaso, Lynn R Goldin, William F Anderson, et al.Pageof 50